Pei-Chun Fan

Title: Pei-Chun Fan: Innovator in Acute Kidney Injury Risk Assessment

Introduction

Pei-Chun Fan is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in assessing the risk of acute kidney injury (AKI) in patients with acute myocardial infarction (AMI). His innovative approach combines molecular biology with clinical applications, showcasing the potential of personalized medicine.

Latest Patents

Pei-Chun Fan holds a patent titled "Method for determining the risk of developing acute kidney injury in a human subject with acute myocardial infarction and inhibiting such development." This patent describes a method that involves obtaining a blood sample and determining the expression levels of specific microRNAs. By calculating the probability of developing AKI based on these levels and a logistic regression model, healthcare providers can identify patients at risk and take preventive measures.

Career Highlights

Throughout his career, Pei-Chun Fan has been associated with prestigious institutions such as Chang Gung University and Chang Gung Memorial Hospital, Linkou. His work has focused on integrating research with clinical practice, aiming to improve patient outcomes through innovative diagnostic methods.

Collaborations

Pei-Chun Fan has collaborated with esteemed colleagues, including Pao-Hsien Chu and Yu-Sun Chang. These partnerships have fostered a collaborative environment that enhances research and development in the field of medical diagnostics.

Conclusion

Pei-Chun Fan's contributions to the assessment of acute kidney injury risk represent a significant advancement in medical diagnostics. His innovative methods and collaborations continue to influence the field, paving the way for improved patient care and outcomes.